搜索临床试验以:批准的抗 PD-1 抑制剂
总计37984个结果
-
Shanghai Jiao Tong University Affiliated Sixth...招聘中
-
Beijing Friendship Hospital尚未招聘
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; The First Affiliated Hospital of University... 和其他合作者撤销
-
Liang PengGuangzhou Virotech Pharmaceutical Co., Ltd.未知晚期/转移性肝细胞癌
-
Shanghai Junshi Bioscience Co., Ltd.未知
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central Hospital撤销
-
Tianjin Medical University Cancer Institute and...招聘中
-
Beijing 302 HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy of Medical Sciences尚未招聘
-
Sichuan University招聘中
-
Beijing 302 HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy of Medical Sciences尚未招聘
-
University of Wisconsin, MadisonBristol-Myers Squibb; National Cancer Institute (NCI); AnYxis Immuno-Oncology GmbH; Provenance Biopharmaceuticals暂停
-
Shanghai Junshi Bioscience Co., Ltd.Iqvia Pty Ltd; TopAlliance Biosciences, Inc.主动,不招人
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer Hospital of Shantou University... 和其他合作者招聘中
-
Providence Health & ServicesMerck Sharp & Dohme LLC; Providence Cancer Center, Earle A. Chiles Research Institute主动,不招人
-
The Fourth Affiliated Hospital of Zhejiang University...招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
National Cancer Institute (NCI)完全的慢性粒单核细胞白血病 | 复发性成人急性髓性白血病 | 伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 先前治疗过的骨髓增生异常综合征 | 复发性成人急性淋巴细胞白血病 | 复发性慢性粒细胞白血病 | 继发性骨髓增生异常综合征 | 成人急性髓性白血病伴 t(15;17)(q22;q12) | 新生骨髓增生异常综合征 | 难治性贫血伴原始细胞过多 | 急变期慢性粒细胞白血病 | 转化中原始细胞过多的难治性贫血美国
-
Sichuan Cancer Hospital and Research Institute尚未招聘
-
Sun Yat-sen UniversityChipscreen Biosciences, Ltd.尚未招聘复发或难治性 DLBCL
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Huiqiang Huang招聘中高级别 B 细胞淋巴瘤 | 转化淋巴瘤 | EBV 阳性 DLBCL,编号 | ALK 阳性间变性大细胞淋巴瘤 | 非 GCB/ABC 弥漫性大 B 细胞淋巴瘤 | 滤泡性淋巴瘤 IIIb 级中国
-
Peking University Cancer Hospital & Institute招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
Calico Life Sciences LLCAbbVie招聘中
-
Sun Yat-sen UniversityShanghai Junshi Bioscience Co., Ltd.主动,不招人